U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07779005) titled 'The Shengjing Lung Cancer Cohort (SJ-LCC) Study on Risk Factors for Disease Development and Progression' on Aug. 19.
Brief Summary: Modifiable risk factors, including smoking, alcohol consumption, and diet, play critical roles in cancer progression and patient prognosis. In patients diagnosed with lung cancer, these risk factors not only directly modulate host metabolism and immune regulation, but also exert indirect effects by altering the internal milieu, such as the gut microbiota-potentially exerting a profound impact on long-term clinical trajectories.
Leveraging a well-characterized, longitudinally followed cohort of confirme...